Kim Vu Tran
Medical · Houston, TXNPI 1326604695
Payments from drug & device makers
Across 274 payments — averaging $24.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurocrine Biosciences, Inc.$1K
- Johnson & Johnson$1K
- Otsuka America Pharmaceutical, Inc.$643
- Teva Pharmaceuticals USA, Inc.$596
- Takeda Pharmaceuticals U.S.A., Inc.$407
- AbbVie$395
- plus $2K from 15 others
What the payments were for
- Food & beverage$6,637100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurocrine Biosciences, Inc. | 38 | $1,456 |
| Johnson & Johnson | 41 | $1,096 |
| Otsuka America Pharmaceutical, Inc. | 29 | $643 |
| Teva Pharmaceuticals USA, Inc. | 20 | $596 |
| Takeda Pharmaceuticals U.S.A., Inc. | 21 | $407 |
| AbbVie | 21 | $395 |
| Sunovion Pharmaceuticals Inc. | 26 | $323 |
| Alkermes, Inc. | 5 | $283 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $223 |
| Idorsia Pharmaceuticals US Inc | 13 | $189 |
| Indivior Inc. | 9 | $169 |
| Corium, LLC | 10 | $149 |
| Supernus Pharmaceuticals, Inc. | 7 | $130 |
| Tris Pharma Inc | 1 | $125 |
| Vanda Pharmaceuticals Inc. | 6 | $122 |
| Lundbeck LLC | 5 | $107 |
| Nestle Healthcare Nutrition Inc. | 2 | $99 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Neuronetics, Inc. | 1 | $24 |
| Eisai Inc. | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INGREZZA$767
- ARISTADA$499
- LYBALVI$463
- SPRAVATO$244
- INVEGA SUSTENNA$239
- AUSTEDO$231
- INVEGA TRINZA$133
- QUVIVIQ$125
- REXULTI$125
- Dyanavel XR$125
- Quillichew ER$125
- Quillivant$125
- ARISTADA INITIO$125
- VRAYLAR$109
How this compares
$6,637 in reported general payments places this provider in the 85th percentile of 1,490 medical providers in Texas.
Other medical in Houston
- Olga RodziyenskaHouston$65K
- Kathleen HoganHouston$26K
- Omni McCluneyHouston$18K
- Carl MayberryHouston$18K
- Carley BuddenbaumHouston$16K
- Jose de la CerdaSan Antonio$1.1M
- Mark DavisFort Worth$1M
- Joey Dixon-JulianBoerne$458K
- Terry FaleyeKingwood$243K
- Kimberly PoarchDallas$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.